Avantor Income After Taxes 2018-2025 | AVTR
Avantor annual/quarterly income after taxes history and growth rate from 2018 to 2025. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
- Avantor income after taxes for the quarter ending March 31, 2025 was $0.065B, a 6.79% increase year-over-year.
- Avantor income after taxes for the twelve months ending March 31, 2025 was $0.716B, a 175.23% increase year-over-year.
- Avantor annual income after taxes for 2024 was $0.712B, a 121.58% increase from 2023.
- Avantor annual income after taxes for 2023 was $0.321B, a 53.23% decline from 2022.
- Avantor annual income after taxes for 2022 was $0.687B, a 19.89% increase from 2021.
| Avantor Annual Income After Taxes (Millions of US $) |
|
|---|---|
| 2024 | $712 |
| 2023 | $321 |
| 2022 | $687 |
| 2021 | $573 |
| 2020 | $117 |
| 2019 | $38 |
| 2018 | $-87 |
| 2017 | $-145 |
| Avantor Quarterly Income After Taxes (Millions of US $) |
|
|---|---|
| 2025-03-31 | $65 |
| 2024-12-31 | $500 |
| 2024-09-30 | $58 |
| 2024-06-30 | $93 |
| 2024-03-31 | $60 |
| 2023-12-31 | $99 |
| 2023-09-30 | $108 |
| 2023-06-30 | $-7 |
| 2023-03-31 | $122 |
| 2022-12-31 | $142 |
| 2022-09-30 | $167 |
| 2022-06-30 | $187 |
| 2022-03-31 | $190 |
| 2021-12-31 | $94 |
| 2021-09-30 | $157 |
| 2021-06-30 | $158 |
| 2021-03-31 | $164 |
| 2020-12-31 | $52 |
| 2020-09-30 | $-42 |
| 2020-06-30 | $60 |
| 2020-03-31 | $47 |
| 2019-12-31 | $71 |
| 2019-09-30 | $22 |
| 2019-06-30 | $-49 |
| 2019-03-31 | $-6 |
| 2018-12-31 | |
| 2018-09-30 | $-32 |
| 2018-06-30 | $-20 |
| 2017-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $9.254B | $6.784B |
| Avantor Inc. is a provider of critical products and services primarily to biopharma, healthcare, education & government, advanced technologies & applied materials industries. Avantor Inc. is based in Radnor, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.850B | 26.98 |
| Elevance Health (ELV) | United States | $84.468B | 10.90 |
| CVS Health (CVS) | United States | $83.959B | 10.44 |
| Cencora (COR) | United States | $56.658B | 19.71 |
| DiDi Global (DIDIY) | China | $22.826B | 24.25 |
| Natera (NTRA) | United States | $22.415B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.653B | 17.56 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.432B | 0.00 |
| Solventum (SOLV) | United States | $12.967B | 13.73 |
| CochLear (CHEOY) | Australia | $12.826B | 0.00 |
| ICON (ICLR) | Ireland | $11.783B | 10.95 |
| Revvity (RVTY) | United States | $11.516B | 19.82 |
| Viatris (VTRS) | United States | $10.434B | 3.58 |
| HealthEquity (HQY) | United States | $8.991B | 39.38 |
| Medpace Holdings (MEDP) | United States | $8.943B | 23.75 |
| Sonic Healthcare (SKHHY) | Australia | $8.181B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.378B | 14.46 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.305B | 25.35 |
| BrightSpring Health Services (BTSG) | United States | $3.975B | 36.47 |
| Sotera Health (SHC) | United States | $3.162B | 17.97 |
| Surgery Partners (SGRY) | United States | $2.782B | 36.18 |
| Alignment Healthcare (ALHC) | United States | $2.710B | 0.00 |
| Concentras Parent (CON) | United States | $2.631B | 15.21 |
| Organon (OGN) | United States | $2.600B | 2.76 |
| GeneDx Holdings (WGS) | United States | $2.537B | 97.72 |
| PACS (PACS) | United States | $1.951B | 0.00 |
| Ardent Health (ARDT) | United States | $1.877B | 8.00 |
| Premier (PINC) | United States | $1.799B | 13.66 |
| Progyny (PGNY) | United States | $1.792B | 39.45 |
| GoodRx Holdings (GDRX) | United States | $1.754B | 35.07 |
| Teladoc Health (TDOC) | United States | $1.328B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.171B | 8.91 |
| Establishment Labs Holdings (ESTA) | $1.084B | 0.00 | |
| CareDx (CDNA) | United States | $1.064B | 16.62 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.999B | 0.00 |
| Agilon Health (AGL) | United States | $0.902B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.840B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.806B | 7.54 |
| Nutex Health (NUTX) | United States | $0.670B | 10.14 |
| LifeMD (LFMD) | United States | $0.584B | 0.00 |
| Embecta (EMBC) | United States | $0.580B | 3.91 |
| InnovAge Holding (INNV) | United States | $0.516B | 0.00 |
| Enhabit (EHAB) | United States | $0.476B | 39.17 |
| Auna S.A (AUNA) | Luxembourg | $0.464B | 10.45 |
| Sonida Senior Living (SNDA) | United States | $0.455B | 0.00 |
| Omada Health (OMDA) | $0.452B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.442B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.301B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.258B | 0.00 |
| Beauty Health (SKIN) | United States | $0.242B | 0.00 |
| Oncology Institute (TOI) | United States | $0.192B | 0.00 |
| So-Young (SY) | China | $0.189B | 0.00 |
| DocGo (DCGO) | United States | $0.165B | 27.00 |
| Pheton Holdings (PTHL) | China | $0.113B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.095B | 0.00 |
| KindlyMD (NAKA) | United States | $0.085B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.075B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| ModivCare (MODV) | United States | $0.049B | 0.00 |
| Biodesix (BDSX) | United States | $0.040B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.038B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |